Can-Fite BioPharma (NYSE:CANF) Now Covered by StockNews.com
StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the stock. Several other brokerages have also issued reports on CANF. HC Wainwright reiterated a “buy” rating and issued a $18.00 price target on shares of Can-Fite BioPharma in […]
StockNews.com started coverage on shares of Can-Fite BioPharma (NYSE:CANF – Get Free Report) in a report issued on Friday. The brokerage set a “sell” rating on the stock. Several other brokerages have also issued reports on CANF. HC Wainwright reiterated a “buy” rating and issued a $18.00 price target on shares of Can-Fite BioPharma in […]
